GeneDx Holdings
SMFR · NASDAQ
$68.74+$2.45 (+3.70%)TodayMarket closed ·
Prev close $66.29
Revenue by product and region
Fiscal year ended Dec 31, 2025: $427.54M total revenue
By product
- Diagnostic test revenue$416.67M97.5%
- Other revenue$10.87M2.5%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Illumina ILMN | Supplier | 0.88 |
| Amazon.com AMZN | Supplier | 0.63 |
| Agilent Technologies A | Supplier | 0.48 |
| OPKO Health OPK | Supplier and customer | 0.26 |
| QIAGEN QGEN | Supplier | 0.19 |
| Danaher DHR | Supplier | -0.01 |
| Alphabet A GOOGL | Supplier | -0.23 |
| Johnson & Johnson JNJ | Customer | -0.32 |
| PerkinElmer PKI | Supplier | -0.33 |
| Roche Holding ROG.SW | Supplier | -0.38 |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.